MJFF's Scientific Advisors: Leading Specialists from Around the Globe
The Foundation's Scientific Advisory Board is a group of leading Parkinson's researchers from both academia and industry, clinicians who work with Parkinson's patients, and experts from related fields. These members come from all over the world to attend grant review assessments, workshops, and other relevant meetings to help determine which research programs will get us closer to improving Parkinson's treatments and curing the disease.
At the Foundation's Research Roundtable events, members of the Scientific Advisory Board also regularly speak to Parkinson's patients and their families about the latest developments in Parkinson's research.
An asterisk (*) following an advisor's name indicates service on the Executive Committee. The Executive Scientific Advisory Board (ESAB) is a seven-member subset of the Scientific Advisory Board that, in addition to customary SAB duties, provides counsel to the Foundation on overarching strategic and programmatic matters several times per year. ESAB membership rotates regularly, on two-year terms, ensuring that a range of voices and opinions play a role in setting the Foundation's strategic direction.
Andrew S. Grove
Former Chairman, Intel Corporation
Santa Clara, California
Gene Johnson, PhD, Chief Scientific Advisor *
Professor
Department of Molecular Biology, Pharmacology & Neurology
Washington University School of Medicine
St. Louis, Missouri
Irene Hegeman Richard, MD, Senior Medical Advisor
Associate Professor of Neurology and Psychiatry
University of Rochester School of Medicine and Dentistry
Rochester, New York
Alberto Ascherio, MD, PhD
Associate Professor
Department of Nutrition
Harvard School of Public Health
Boston, Massachusetts
Erwan Bezard, PhD *
INSERM Researcher
Universite Victor Segalen-Bordeaux 2
Bordeaux , France
Anders Björklund, MD, PhD
Professor
Department of Neurobiology
Wallenberg Neuroscience Center, Lund University
Lund , Sweden
Susan Bressman, MD
Professor of Neurology
Albert Einstein College of Medicine
New York, New York
Robert E. Burke, MD
Director, Laboratory Research in Parkinson's Disease and Related Disorders
Neurology Department
Columbia-Presbyterian Medical Center
New York, New York
Marie-Francoise Chesselet, MD, PhD
Charles H. Markham Professor of Neurology
Department of Neurology
David Geffen School of Medicine, University of California
Los Angeles, California
P. Jeffrey Conn, PhD *
Professor, Director, Program in Translational Neuropharmacology
Department of Pharmacology
Vanderbilt University Medical Center
Nashville, Tennessee
Mark Cookson, PhD
Chief, Cell Biology and Gene Expression
National Institute on Aging
Bethesda, Maryland
David Eidelberg, MD
Director, Center for Neuroscience
Feinstein Institute for Medical Research
Long Island, New York
Matt Farrer, PhD
Consultant/Associate Professor, Genetics of Parkinson's & Related Disorders
Department of Neuroscience
Mayo Clinic
Jacksonville, Florida
Chip Gerfen, PhD
Chief
Laboratory of Systems Neuroscience
National Institute of Mental Health
Bethesda, Maryland
J. Timothy Greenamyre, MD, PhD
Director, Pittsburgh Institute for Neurodegenerative Diseases
Chief, Division of Movement Disorders
University of Pittsburgh
Pittsburgh, Pennsylvania
Etienne Hirsch, PhD
Director
Experimental Neurology & Therapeutics
INSERM & Pierre et Marie Curie Paris 6 University
Paris , France
Oleh Hornykiewicz, MD
Professor Emeritus
Department of Biochemical Pharmacology
University of Vienna
Vienna , Austria
Ole Isacson, MD (Dr Med Sci)
Professor
Department of Neurology
Neuroregeneration Center, McLean Hospital
Belmont, Massachusetts
Joseph Jankovic, MD
Professor, Department of Neurology
Director, Parkinson's Disease Center and Movement Disorders Clinic
Baylor College of Medicine
Houston, Texas
Jennifer Johnston, PhD
Principal Scientist
Elan Pharmaceuticals
San Francisco, California
Jeffrey H. Kordower, PhD
Director, Research Center for Brain Repair; The Jean-Schweppe Armour Professor of Neurological Sciences
Rush University Medical Center
Chicago, Illinois
J. William Langston, MD
Scientific Director and Chief Executive Officer
The Parkinson's Institute
Sunnyvale, California
Olle Lindvall, MD, PhD *
Professor, Department of Neurology
Laboratory of Neurogenesis and Cell Therapy, Section of Restorative Neurology
Wallenberg Neuroscience Center
Lund , Sweden
Andres Lozano, MD, PhD
Professor of Neurosurgery and Head of Applied and Interventional Research
Toronto Western Hospital
Toronto , Canada
Kenneth L. Marek, MD *
President and Senior Scientist
Institute for Neurodegenerative Disorders
New Haven, Connecticut
Eldad Melamed, MD
Professor of Neurology
Sackler School of Medicine, Tel Aviv University
Tel Aviv , Israel
Kalpana Merchant, PhD *
Chief Scientific Leader, Integrative Biology
Eli Lilly and Company
Indianapolis, Indiana
C. Warren Olanow, MD
Chariman and Professor
Department of Neurology
Mount Sinai School of Medicine
New York, New York
Theo Palmer, PhD
Assistant Professor
Department of Neurosurgery
Stanford University
Palo Alto, California
Ira Shoulson, MD
Louis C. Lasagna Professor of Experimental Therapeutics
Department of Neurology, Medicine & Pharmacology
University of Rochester
Rochester, New York
Andrew Singleton, PhD
Chief, Molecular Genetics Unit
Laboratory of Neurogenetics
National Institute on Aging/NIH
Bethesda, Maryland
David Standaert, MD, PhD *
John and Juanelle Strain Professor of Neurology
Director, Center for Neurodegeneration and
University of Alabama at Birmingham
Birmingham, Alabama
Dennis A. Steindler, PhD
Professor of Medical Research
Department of Neuroscience and Neurosurgery
McKnight Brain Institute
Gainesville, Florida
Caroline M. Tanner, MD, PhD
Director of Clinical Research
The Parkinson's Institute
Sunnyvale, California
David Weiner, MD
Senior Medical Director
Neurology Global Development Unit
EMD Serono Inc.
Rockville, Massachusetts
Michael J. Zigmond, PhD
Professor
Department of Neurology and Psychiatry
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
